Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
IP.BK
Strong BuyFull HouseInter Pharma Public Company Limited · Healthcare · Thailand · $90M · Avg Vol: $53K/d
COMPANY DESCRIPTION
Inter Pharma Public Company Limited manufactures, imports, and distributes drug and dietary supplement products for humans and animals in Thailand. It operates through three segments: Human healthcare, Animal healthcare, and Hospital and clinics.
FINANCIAL SUMMARY (THB)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM |
|---|---|---|---|---|---|---|
| Revenue | 1.5B | 1.8B | 1.9B | 2.2B | 12.9% | 2.3B |
| EPS (THB) | 0.22 | 0.08 | 0.06 | 0.20 | -3.3% | 0.23 |
| Shares | 605.3M | 605.3M | 605.3M | 605.3M | -0.0% | 605.3M |
| Debt | 539.0M | 399.7M | 394.4M | 400.9M | -9.4% | 363.3M |
| Equity | 1.9B | 1.9B | 1.9B | 2.1B | 2.2% | — |
| Op CF | 143.1M | 121.4M | 177.8M | 307.9M | 29.1% | 239.9M |
| Inv CF | -588.1M | -232.8M | -310.0M | -170.5M | — | — |
| Fin CF | 1.0B | -252.9M | -95.4M | -41.3M | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of IP.BK are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| IP.BK | Inter Pharma Public Company Limited(you) | $90M | 93 | Strong Buy |
| NTV.BK | Nonthavej Hospital Public Company Limited | $93M | 89 | Strong Buy |
| TOG.BK | Thai Optical Group Public Company Limited | $102M | 90 | Strong Buy |
| RPH.BK | Ratchaphruek Hospital Public Company Limited | $79M | 89 | Strong Buy |
| RJH.BK | Rajthanee Hospital Public Company Limited | $135M | 95 | Strong Buy |
| BIZ.BK | Business Alignment Public Company Limited | $111M | 100 | Strong Buy |
| EKH.BK | Ekachai Medical Care Public Company Limited | $127M | 88 | Strong Buy |
| VIH.BK | Srivichaivejvivat Public Company Limited | $160M | 98 | Strong Buy |
| TNH.BK | Thai Nakarin Hospital Public Company Limited | $156M | 79 | Buy |
| SKR.BK | Sikarin Public Company Limited | $483M | 92 | Strong Buy |
Peer medians: ROE 12.2% · P/E 14.6x · Gross margin 27.9%